Regeneron (REGN) Tops Q2 EPS by $1.17
Tweet
Share
E-mail
Get Alerts REGN Hot Sheet
Price: $797.99 +0.12%
Financial Fact:
Selling, general, and administrative: 270.05M
Today's EPS Names:
COHR, LVWD, FWDI, More
Financial Fact:
Selling, general, and administrative: 270.05M
Today's EPS Names:
COHR, LVWD, FWDI, More
Join SI Premium – FREE
Regeneron (NASDAQ: REGN) reported Q2 EPS of $9.77, $1.17 better than the analyst estimate of $8.60. Revenue for the quarter came in at $2.86 billion versus the consensus estimate of $2.79 billion.
For earnings history and earnings-related data on Regeneron (REGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AEVEX Corp. (AVEX) Reports Q2 EPS of $0.01; offers guidance
- Aviragen Therapeutics (AVIR) Tops Q2 EPS by 15c
- BioStem Technologies, Inc. (BSEM) Misses Q3 EPS by 44c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
